Rukminiati, Yuni
Mesak, Felix
Lolong, Dina
Sudarmono, Pratiwi
Article History
Received: 2 January 2024
Accepted: 11 June 2024
First Online: 25 June 2024
Declarations
:
: Following an informed consent of the nationwide trial, patients with new or re-treated TB at various Indonesian community clinics were recruited to the study. The Indonesian National Ethics Committee Ministry of Health, Health Institute for Research and Development (<i>Komisi Etik Litbangkes Kemenkes RI</i>) gave its approval to the current study. All methods were performed according to the guidelines described in the study protocol of the national drug resistance survey of the Indonesian Ministry of Health. Informed consent was formally signed by patients. All patients who were identified as having TB or drug-resistant TB received proper care. The research was carried out in conformity with the principles of the Helsinki Declaration.
: Not applicable.
: The authors declare no competing interests.